|
Expression-Based Multi-Gene Signatures for CRC Recurrence and Chemoselection
|
2R44CA119565-05
|
$999,610
|
$999,610
|
Sears, Christopher
|
AMBERGEN, INC
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
5U01CA098710-07
|
$312,578
|
$312,578
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
|
Roles of Zinc Transporter ZIP4 (SLC39A4) in Pancreatic Cancer Pathogenesis
|
5R21CA133604-02
|
$202,620
|
$50,655
|
LI, MIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-04
|
$3,089,219
|
$92,677
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S6
|
$100,000
|
$3,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-04S1
|
$250,400
|
$7,512
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genomic Approaches to Defining Inherited Basis of Childhood Cancer
|
1R01CA138836-01A2
|
$627,215
|
$627,215
|
PLON, SHARON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-15
|
$342,796
|
$342,796
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
2R01CA079830-09A1
|
$330,099
|
$330,099
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
3P50CA105009-05S2
|
$500,000
|
$250,000
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Partners Southwestern Clinical Epidemiology/Validation
|
3U01CA086381-10S1
|
$271,800
|
$271,800
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Biochemical Markers in the Nurses? Health Study Cohort
|
5U01CA049449-21
|
$1,136,977
|
$909,582
|
Hankinson, Susan
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cohort Study of Genetic Susceptibility to Breast Cancer
|
5R01CA065725-14
|
$409,590
|
$409,590
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
|
5U01CA098233-08
|
$1,135,499
|
$1,135,499
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Mitochondrial Genome and Skin Cancer Risk
|
5R03CA141606-02
|
$89,000
|
$89,000
|
Nan, Hongmei
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes
|
5K07CA120448-04
|
$141,548
|
$141,548
|
STOFFEL, ELENA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mitochondrial DNA Mutations in Pancreatic Cancer
|
5R21CA133080-02
|
$93,181
|
$93,181
|
Tranah, Gregory
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Ontario Familial Breast Cancer Registry
|
5U01CA069467-16
|
$651,917
|
$651,917
|
ANDRULIS, IRENE
|
CANCER CARE ONTARIO
|
|
Northern California Cooperative Family Registry for Breast Cancer
|
5U01CA069417-16
|
$1,471,033
|
$956,171
|
JOHN, ESTHER
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Familial Barrett's Esophagus Summit
|
1R13CA144432-01
|
$10,000
|
$2,500
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Clinical Correlative Studies of Neuroblastoma
|
5R01CA060104-17
|
$428,770
|
$428,770
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome
|
1R01CA143167-01
|
$355,729
|
$355,729
|
Hill, Dana
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-19
|
$266,860
|
$266,860
|
BIEGEL, JACLYN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Molecular Genetic Analysis of Human Neuroblastoma
|
5R01CA039771-22
|
$388,815
|
$388,815
|
BRODEUR, GARRETT
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Cytogenetic and Molecular Studies of Chromosome 22
|
5R01CA039926-22
|
$377,541
|
$377,541
|
EMANUEL, BEVERLY
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-03
|
$667,730
|
$667,730
|
MARIS, JOHN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
THE PATHOGENESIS OF DYSKERATOSIS CONGENITA
|
2R01CA106995-06A1
|
$323,081
|
$323,081
|
MASON, PHILIP
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
3P30CA033572-27S1
|
$94,753
|
$3,790
|
friedman, michael
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-27S2
|
$100,000
|
$4,000
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-27S3
|
$101,205
|
$4,048
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-27S4
|
$151,808
|
$6,072
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-27
|
$2,318,695
|
$92,748
|
friedman, michael
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
The IGF Signaling Pathway and Breast Cancer Risk
|
7R01CA116494-04
|
$518,526
|
$518,526
|
Neuhausen, Susan
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CpG methylation and mutation
|
5R01CA084469-11
|
$291,816
|
$291,816
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Genetics Career Development Program
|
5R25CA085771-10
|
$220,638
|
$11,032
|
WEITZEL, JEFFREY
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Roles and Regulation of p53
|
5P01CA087497-10
|
$1,668,201
|
$200,184
|
Prives, Carol
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Cancer Center Support Grant
|
3P30CA013696-37S1
|
$100,000
|
$5,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-37
|
$4,017,288
|
$200,864
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
AIDS Associated Lymphoproliferative Disorders
|
5R37CA037295-27
|
$402,500
|
$402,500
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Assessment of Inherited Colon Cancer Prediction Models in Diverse Populations
|
1K07CA151769-01
|
$170,416
|
$170,416
|
Kastrinos, Fay
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A pilot study of statin therapy and risk of malignant glioma
|
5K07CA127468-03
|
$135,513
|
$67,757
|
Lai, Rose
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Metropolitan New York Regisry of Breast Cancer Families
|
5U01CA069398-17
|
$560,142
|
$560,142
|
TERRY, MARY BETH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
EDRN: Clinical Epidemiology & Validation Centers
|
3U01CA086389-10S1
|
$143,335
|
$107,501
|
LYNCH, HENRY
|
CREIGHTON UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S1
|
$124,531
|
$4,981
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S2
|
$100,000
|
$4,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S3
|
$100,000
|
$4,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S4
|
$46,458
|
$1,858
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
$465,671
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Epidemiology of Syndromic GI Stromal Tumors
|
5R01CA125176-04
|
$449,094
|
$449,094
|
GARBER, JUDY
|
DANA-FARBER CANCER INSTITUTE
|
|
High-throughput oncogene mutation detection in human cancer
|
4R33CA126674-03
|
$292,410
|
$292,410
|
GARRAWAY, LEVI
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Genetic Testing for this search: $120,222,265
|